Recruiting PKU Studies in Palo Alto
About PKU Clinical Trials in Palo Alto
Phenylketonuria (PKU) is an inherited metabolic disorder that increases levels of the amino acid phenylalanine in the blood, which can cause intellectual disability if untreated. Early detection through newborn screening is essential. Treatment includes a strict low-phenylalanine diet and enzyme substitution therapy.
There are currently 1 pku clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 38 participants. Research is being sponsored by Maze Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
PKU Clinical Trials in Palo Alto — FAQ
Are there pku clinical trials in Palo Alto?
Yes, there are 1 pku clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What pku treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for pku.
Data updated August 27, 2026 from ClinicalTrials.gov